Related by context. All words. (Click for frequent words.) 71 Evidence Therapeutic 69 placebo controlled dose escalation 69 EXPLORE Xa 69 blinded randomized placebo controlled 69 randomized controlled multicenter 68 ADMIRE HF 68 controlled multicenter 68 recombinant PSMA vaccine 67 recurrent metastatic ovarian cancer 67 sapacitabine CYC# 67 registrational Phase 67 confirmatory clinical 67 ORAL Solo 67 Bayer HealthCare Onyx Pharmaceuticals 67 REVIVE TA 67 ADVANCE ILLUMINATE 66 designated HVTN 66 EOquin TM phase 66 subcutaneous PRO 66 number NCT# ClinicalTrials.gov 66 Phase Ib IIa 66 landmark ATHENA 66 BRIM2 65 Randomized Double blind 65 BARI 2D 65 HCV SPRINT 65 evaluating Actimmune 65 randomized multicenter 65 multicentre randomized 65 solid tumors ZYBRESTAT 65 initiate multicenter 65 prospective multicentre 65 double blinded randomized 65 multicenter Phase II 65 AVOREN 65 NO# [002] 65 malignant mesothelioma Alfacell 65 TMC# C# 65 multicentre randomized double 65 ACCEDE 65 Oral NKTR 65 Randomized Phase II 65 pharmacogenomic translational research 65 Phase III multicenter 65 controlled multicenter Phase 65 PROTECT AF 64 CTA# Injection 64 Budesonide foam crofelemer 64 evaluating tesamorelin 64 RECORD1 64 ABSORB clinical 64 CARE HF 64 Randomized controlled 64 Empatic ™ 64 Phase Ib II 64 By LEO SHANE 64 multinational multicenter randomized 64 BY ADRIAN NEMES 64 trastuzumab emtansine T DM1 64 comparing XIENCE V 64 ICON7 64 multicenter Phase III 64 HCV NS5B polymerase 64 pivotal bioequivalence 64 Tor Bjerkedal report 64 Phase IIb randomized 64 REVIVE Diabetes 64 Gabriel Mollet 63 prospective randomized multicenter 63 undergoing elective percutaneous 63 treatment naive genotype 63 Second Pivotal Phase 63 multicenter placebo controlled 63 dose escalation Phase 63 IIa clinical 63 BRIM3 63 phase IIIb 63 XL# anticancer compounds 63 PARTNER Trial 63 Dose Limiting Toxicity DLT 63 Park Debate Colester 63 STRIKE PRICE COMPARES TO 63 INSPIRE Trial Phase III 63 MEND CABG 63 multicenter randomized double 63 CHAMPION PCI 63 multicenter randomized placebo controlled 63 BCIRG 63 thorough QT 63 HGS ETR1 mapatumumab 63 PRIMO CABG2 63 STAR WARS ARCHIVES EPISODES 63 dose escalation phase 63 budesonide MMX Phase III 63 RIO Diabetes 63 biostatistical analysis 63 Maximum Tolerated Dose MTD 63 CATIE AD 63 MYTHOS trial 63 multicenter randomized controlled 63 ThermoDox ® clinical 63 blinded randomized 63 eye socket ruptured bladder 63 CONQUER OB 62 multicenter phase 62 SIMPADICO 62 PRIMO CABG 62 ONTARGET 62 TEC #OL 62 Randomised 62 By JENNIFER LEARN 62 read Palintologist 62 CEL SCI Phase III 62 kidney urologic 62 commercialize CorMedix drug 62 Puritan rigidity 62 Phase III placebo controlled 62 placebo controlled Phase 62 ExTRACT TIMI 62 CG# oncolytic virus 62 label multicenter randomized 62 SUTENT ® 62 verdict elicited gasps 62 dose escalation clinical 62 oral rivaroxaban 62 EQUIP OB 62 Callisto initiated 62 QLT Plug Delivery 62 clinical trials Archexin 62 prednisone prednisolone plus 62 Phase III metastatic melanoma 62 CFRA forensic accounting 62 La. Protests Hark 62 RE LY 62 placebo controlled clinical 62 By Arek Sarkissian 62 Initiated Phase 62 Dose Ranging 62 EchoCRT 62 opioid naive 62 Phase IIb III 62 PCI ExTRACT TIMI 62 AVN# Phase 62 tribulations Groenveld 62 CURE AF 62 www.timminco.com following 62 nonrandomized 62 ACCORD Eye 62 randomized controlled Phase 62 rALLy clinical trial 62 RAS MAPK pathway 62 ROCKET AF 62 dimebon latrepirdine 62 phase Ib 62 Zemplar Capsules 62 BY DAVID CRIGGER 62 multicentre randomized controlled 62 Ruined temples 62 oral picoplatin 62 KYLE BUSCH DRIVER 62 blind multicenter 62 testing huN# DM1 62 Muscular colt 62 multicenter prospective 62 telemonitoring imaging 62 Wisconsin Sleep Cohort 62 placebo controlled Phase III 62 rib cage mangled 62 Val HeFT 62 LUX Lung 62 Phase Ib clinical 62 randomized multicentre 62 Prostate AdenoCarcinoma Treatment 61 EXECUTIVE SUMMARY II 61 HCV RESPOND 2 61 Uhhhhh Bosh 61 relapsed MM 61 Sorafenib HCC Assessment 61 PORxin TM platforms 61 DASISION 61 phase IIb clinical 61 placebo controlled randomized 61 Huggins Cams Time 61 Phase 1a clinical 61 STRIDE PD 61 FOLFOX6 chemotherapy regimen 61 evaluating satraplatin plus 61 prospective randomized controlled 61 CAPACITY trials 61 Randomized Phase III 61 Proellex TM 61 ACCORD Lipid 61 TESTIMONY FROM 61 ENESTnd 61 imetelstat GRN#L 61 CALGB 61 randomized Phase III 61 Phase III confirmatory 61 blinded placebo controlled 61 grilled cheese grilled 61 AKT inhibitor 61 XL# SAR# 61 YOUR LOCAL ANIMAL SHELTER 61 Phase III randomized 61 Evidence Therapeutic study 61 pexelizumab trials 61 Primary endpoints 61 unique alkylating agent 61 treatment naïve genotype 61 STEALTH C 61 Daniel Popko 61 Raloxifene Evaluation MORE 61 evaluating mipomersen 61 Teriflunomide 61 Nambu theories permeate 61 cathepsin K inhibitor 61 Independently Dyax 61 ABL inhibitor completing 61 EURIDIS 61 multicenter randomized 61 prospective multicenter 61 maximally tolerated dose 61 Carotid Revascularization Endarterectomy vs. 61 EMPOWER ™ 61 Jack Pirozzolo 61 WESLEYAN IN 61 NATIONAL ECONOMIC COUNCIL DIRECTOR 61 Ahmed Refaat Saad 61 multicenter Phase 61 HARD ENOUGH WITH 61 Crofelemer budesonide foam 61 BLOOM Behavioral modification 61 IT HARD TO 61 By CASSIE HEWLINGS 61 deCODE AF TM 61 intravenous picoplatin include 61 surveys Herbenick 61 randomized blinded 61 KN excels 61 multicenter dose escalation 61 phase IIa clinical 61 visit http:/www.aberdeen.com/link/sponsor.asp?spiSautner ruled 61 ug dose 61 agents Tabun Sarin 61 Deltagen Reports 60 MEND CABG II 60 Intervention Effectiveness 60 Clinical Antipsychotic Trials 60 alvespimycin 60 label multicenter 60 metaglidasen 60 CAMMS# Phase 2 60 warships patroling 60 Kurylowicz trial 60 MKC# MKC# PP 60 azilsartan medoxomil 60 evaluating satraplatin 60 THE UNDERLYING FUTURE 60 Placebo controlled 60 multicentre prospective 60 Pharmacokinetic parameters 60 Terra Incognita Golden 60 HOW LONG WAS 60 StockPickReport.Com ranks stocks 60 evaluating tivozanib 60 AVERROES 60 By HARVEY SIMPSON 60 By Samantha Pidde 60 RE MODEL 60 #-THOUSAND DOLLAR 60 IMPACT DCM 60 CURRENT OASIS 7 60 GetGoal Phase III 60 Phase #/#a 60 ANCHOR trial 60 PEGylated docetaxel 60 Refrigerate sliced 60 metastatic HRPC 60 ALSYMPCA 60 recurrent malignant glioma 60 entrepreneur futurist 60 CYT# potent vascular disrupting 60 viral kinetic 60 Farfan Juan Pablo 60 GENASIS 60 TEMSO 60 evaluating T DM1 60 label dose titration 60 phase IIa 60 MADIT II 60 evaluating Vectibix 60 #-# Lexus IS#/IS# 60 Phase 2b randomized 60 evaluating Xcytrin 60 riociguat 60 Edge STudy 60 #/#/# Cytokinetics Incorporated 60 sequential dose escalation 60 ACTIVE W 60 USHE groundbreaking pocket BLU 60 PMX # heptagonist 60 Custirsen 60 CALGB # [002] 60 formal pharmacokinetic PK 60 active comparator 60 class mGluR5 inhibitor 60 DEB# 60 cardiac myosin activator omecamtiv 60 initiated confirmatory Phase 60 venlafaxine XR 60 By PETER LARSEN 60 tape echo multitrack 60 infliximab monotherapy 60 MSI #F 60 assaying protocols 60 visilizumab 60 prospective randomized placebo 60 Phase 1b clinical trials 60 dose escalation trial 60 By DAVE BUCHANAN 60 GAMMAGARD 60 LongHorn chefs love 60 dose dose escalation 60 R# #mg BID 60 EDEMA3 60 Mg Usa 60 ongoing Phase IIIb 60 LIVERPOOL WILL NEVER 60 Multiple Ascending Dose 60 cancer indications bafetinib 60 tolerability pharmacokinetics 60 Phase Ib clinical trials 60 IMPDH inhibitor 60 JK Rowling Scholastic FP 60 Phase IIIb 60 By Gene Haschak 60 ENDEAVOR IV 60 tramiprosate Alzhemed TM 60 Multicenter Automatic Defibrillator Implantation 60 ToGA 59 ENDEAVOR IV clinical 59 Perifosine KRX 59 dirucotide MBP# 59 label multicenter Phase 59 NEUVENGE 59 includes TOLAMBA TM 59 AERAS-#/Crucell Ad# 59 Chevrolet Malibu #.#L I4 59 Trastuzumab DM1 59 MKC# MT 59 brown baggers #x# 59 #-#-#-#-# Picture 59 fusion enhancers 59 Randomized Phase 59 Active Ulcerative Colitis 59 multicenter multinational 59 candidate CRLX# 59 multicenter clinical 59 evaluating carfilzomib 59 management biostatistical analysis 59 Giants Kiick 59 Phase III ADT 59 acyclovir Lauriad R 59 PD2i CA Cardiac Analyzer 59 VEGFR2 inhibitor 59 4BETTER OR WORSE 59 Opera Recording Humperdinck 59 STACY LEE 59 crowed Kara DioGuardi 59 cladribine Cladribine Tablets 59 Aeolus Pharmaceuticals Announces 59 By Ted Holteen 59 specific CCR9 antagonist 59 Emil Protalinski Published 59 APEX PD 59 retinal thrombosis hemorrhages 59 intravenous CK # 59 CYTEC INDUSTRIES 59 Camm extramarital affairs 59 confidential informants linking 59 multicentre 59 Trial Issue www.emagazine.com 59 ADVANCE PD 59 galiximab 59 Sprite Fanta Mello Yello 59 TRITON TIMI 59 Multicenter Phase 59 continue Hachimine 59 staphylococcal vaccine 59 TG MV 59 Telik logo TELINTRA 59 Intravenous palifosfamide 59 humanized therapeutic 59 Musician Flaco Jimenez 59 ZYBRESTAT fosbretabulin 59 double blinded placebo 59 Phase lll 59 Alimentary Tract 59 Actress Lela Rochon 59 ENABLE Phase 2 59 ENMD # 59 ongoing Phase 1b 59 teriflunomide 59 prospective observational studies 59 REMINYL ® 59 retrospective observational 59 EMPOWER TM 59 Laura Leyshon 59 Subjecting prisoner abuse 59 ur loo 59 kitchen wine cellars 59 Hornbeck Offshore Announces 59 ACTEMRA TM 59 Initiates Phase II 59 Planetwide Media My 59 bepotastine besilate nasal spray 59 var arrContent = 59 Randomized phase 59 evaluating picoplatin 59 PLX STROKE targeting 59 initiate Phase 1b 59 methodologically rigorous 59 Truvada tablets 59 SUCCEED trial 59 Arch Surg 59 randomized Phase 2b 59 RE SURGE 59 Newsroom VIDEO Kamahl slams 59 prospective observational cohort 59 compound INCB# 59 Proc Am Soc 59 TAXUS V 59 Fovea Pharmaceuticals subsidiary 59 novel VDA molecule 59 Phase 1b clinical 59 Trandolapril 59 r h r 59 LabCorp conducts clinical 59 CALERIE 59 PROTEGE 59 LibiGel Phase III 59 somatostatin analog 59 irinotecan cisplatin 59 OBPM 59 Volumex Daxor single 59 By TOM LOUNSBERRY 59 ASTEROID 59 6 sulfatase 59 asymptomatic metastatic 59 Review Engagements ASRE 59 PDX pralatrexate 59 sandwiches cole slaw 59 novel orally inhaled 59 Phase III AFFIRM 59 worsening thrombocytopenia 59 CAPRIE 59 visit http:/www.clinicaltrials.gov/ 59 CAMMS# 59 JAK inhibitor 59 NSABP B 59 MAGE A3 ASCI 59 CLARITY study 59 PRECiSE 59 MIST II 59 HORIZONS AMI trial 59 GENASIS clinical 59 mecarbil 58 plus prednisone prednisolone 58 HIV RDEA# 58 GERD migraine headaches 58 NEVO RES 58 Phase #b/#a clinical 58 Suzanne Elsworth 58 Secondary efficacy endpoints 58 MKC# 58 intravesical infusion therapy 58 LCP AtorFen 58 rash pruritus nausea 58 TAXUS VI 58 MEN CHARGED 58 starred Ursula Andress 58 Acetavance TM intravenous acetaminophen 58 mertansine 58 monoclonal antibody biologic 58 PRESS BRIEFING #AM 58 ISPO institute 58 prospective multicenter randomized 58 Deforolimus 58 HGS ETR2 58 CTAP# Capsules 58 phase IIb study 58 multicenter randomized clinical 58 Glufosfamide 58 Group Ridin Chamillionaire 58 Shiwakoti wrinkled 58 confirmatory pivotal 58 By LYNDSAY MOSS 58 Refractory Angina 58 CCX# B 58 ABCSG 58 Pre RELAX AHF 58 LUCK Happy Birthday 58 sunitinib malate 58 TIMET Reports 58 Rs. MT 58 AzaSite ISV 58 multicenter randomized Phase 58 Dojack faces 58 interferon gamma 1b 58 TRISCUIT Samples 58 TAXUS ATLAS 58 precaution Wiehle 58 Raptiva r 58 APEX AMI 58 ORAL Sync 58 morphometric vertebral fractures 58 DO YOU NEED TO 58 dihydroergotamine mesylate DHE 58 anti VEGF aptamer 58 RE LY ® 58 prospective nonrandomized 58 Oral Fingolimod 58 NSABP C 58 contact Analytiqa 58 By Doris Yon 58 Biomerix Corporation 58 Biochip Array Technology 58 Recurrent Glioblastoma 58 Exelixis compounds 58 trastuzumab DM1 T DM1 58 LymphoStat B belimumab 58 Towering scholar 58 relapsing remitting MS RRMS 58 GEM OS2 58 Albuferon Phase 58 metastatic ocular 58 AND SCRIPTS ARE AVAILABLE 58 http:/www.investorsobserver.com/freemo2 58 ASCEND HF 58 Initiate Phase 58 Jeff Altimar jumper 58 aplindore 58 Greek sprinters Katerina 58 LAB CGRP 58 ragweed allergy immunotherapeutic 58 DEEP AF 58 TAXUS IV 58 DAPT 58 Aflibercept 58 Targretin capsules 58 COU AA 58 By Amy Boerema 58 element ICP analysis 58 coronary stent merged 58 CRLX# 58 ConclusionThis 58 randomized controlled clinical 58 pharmacodynamic profiles 58 Medullary Thyroid Cancer 58 lawmaker Hosseini Sobhaninia 58 Sherlock uncovering 58 AIR CF2 58 HCD# [002] 58 serine protease inhibitor CU# 58 VICTOR E1 58 #:# randomization 58 de novo kidney transplant 58 recurrent glioblastoma multiforme 58 By WILLIAM KELLY 58 YONDELIS 58 novel emulsion formulation 58 MERLIN TIMI 58 basal bolus regimen 58 Grifters costar Bening 58 Testosterone MDTS ® 58 safety tolerability pharmacokinetic 58 Hsp# Inhibitor 58 FULL IMPACT 58 var arrMeta = 58 Natural Catastrophe Stress 58 phase IIb 58 Lavilla Capener • 58 retinal vein occlusion induced 58 LVL MDF plywood 58 pharmacokinetic pharmacodynamic 58 CHASKA Minn. YE Yang 58 Rigel R# 58 oral ridaforolimus 58 NATRECOR R 58 AAG geldanamycin analog 58 g r 58 BR.# 58 prospectively stratified 58 #,# WeddingWire newlyweds 58 WLK appears 58 Evgeny Novikov Mitsubishi Lancer 58 randomized discontinuation 58 safety tolerability pharmacokinetics 58 EVEREST II 58 oral Janus kinase 58 dosing cohorts 58 Sapacitabine 58 antidepressants fluoxetine 58 Prostate Lung Colorectal 58 Contrave# 58 blinded randomized controlled 58 MediGene focuses 58 evaluating adecatumumab 58 melphalan prednisone 58 ALN VSP Phase 58 TRIOLEX HE# APOPTONE HE# 58 HORIZONS AMI 58 HF ACTION 58 next generation URAT1 58 oral deforolimus 58 icatibant 58 Prospective Randomized 58 OFFICIAL CAPACITY AS 58 naïve HCV 58 NS5B polymerase 58 mediations arbitrations 58 juice iced teas 57 prehistoric Qesem cave 57 REALITY Trial 57 SBRB conducts these 57 NCCTG 57 factorial design 57 FOB Ningbo price 57 SORT OUT III 57 Telik Announces 57 PrevOnco 57 Pruvel ™ prulifloxacin 57 lorcaserin Phase 57 pain palliation 57 By Gina Delfavero 57 Strangers kissed 57 R BorderGuard 57 Dialysis Outcomes 57 medtech insight 57 lintuzumab SGN 57 Robert Rusert 57 Phase Ib study 57 CINQUIL 57 Medidur TM FA 57 bazedoxifene conjugated estrogens 57 Combination REOLYSIN R 57 PERSEUS clinical program 57 selective androgen receptor modulator 57 oral ghrelin agonist 57 Quepasa Corporation headquartered 57 Regulatory Disclosure 57 CA9 SCAN 57 Meta analyzes 57 product TNFerade TM 57 journal Gynecologic Oncology 57 PHX# 57 Division IA Conferences 57 Zenvia ™ 57 initiated Phase Ib 57 NOXAFIL Oral Suspension 57 www.virtualiron.com 57 forodesine 57 Left Ventricular Dysfunction 57 Spine Patient Outcomes 57 PEGINTRON REBETOL combination 57 LEVAQUIN ® 57 paclitaxel poliglumex 57 human IgG1 monoclonal 57 Genz # 57 PATENT FOR 57 Endovascular Valve Edge 57 label dose escalation 57 ancrod 57 Voir dire 57 neratinib 57 WISCONSIN STAT 57 Rigorous scientific 57 stage IIIb IV 57 Tumor Response 57 Namenda Memantine HCl 57 PROTECT II 57 Kinesin Spindle Protein KSP 57 motesanib 57 RIO Lipids 57 AP IMPACT Credibility 57 mg administered orally 57 Post hoc 57 bevirimat Study 57 HDL Selective Delipidation 57 XL# XL# XL# 57 unpartnered guanosine nucleotide analog 57 Completes Patient Enrollment 57 & Analgesia retracted 57 EmbraceAC 57 randomized Phase IIb 57 prospectively defined 57 Columnist Filip Bondy 57 REG2 57 confirmatory Phase III 57 midstage clinical 57 y h r 57 pharmacodynamic effects 57 immunotherapeutic approaches 57 albiglutide 57 Dose Escalation 57 FIX HF 5 57 cardio renal 57 Alpha Tocopherol Beta Carotene 57 Eniluracil 57 code Cu AA# 57 desvenlafaxine succinate 57 Amigal TM 57 pharmacokinetics PK 57 washer dryers heaters 57 clinical trials Archexin ® 57 CLARITY TIMI 57 Silodosin 57 Hypertensive adverse reactions 57 Hematide ™ 57 exclaimed Cranston 57 TKB# 57 MGd 57 PrimeSuite integrates practice 57 THAT ARE DIFFICULT TO 57 STRANGE de 57 Aldurazyme R 57 Randomized Double Blind 57 regorafenib 57 mg Pycnogenol 57 SUSAN WORLEY Star 57 Initiates Phase III 57 Zevalin consolidation 57 Synta Announces 57 develop HBV reactivation 57 bile duct tumor 57 CLL8 57 insane epistolary monologue 57 CIMZIA TM certolizumab pegol 57 LUMINATE 57 evaluating intravenous picoplatin 57 By ANDREW GLASS 57 OPT CHF 57 preclinical efficacy 57 Mummies Death 57 CD#.# DOES NOT ENDORSE 57 BOLDER II 57 Tyrima 57 BiTE R 57 phase III ACCLAIM 57 Successfully Completes Phase 57 SPIRIT FIRST 57 SYMMETRY trial 57 Denver Mocapay 57 OLYMPIA registry 57 Sentient specializes 57 partner Lux Biosciences 57 requiring Asthmatx 57 GREEN MILL 57 IMPROVE HF 57 inflammatory PDE 57 observer blinded randomized 57 Tovaxin Phase IIb 57 virus HCV protease inhibitor 57 ALN HPN 57 By Orrin Schwarz 57 Novo TTF 57 unresectable Stage III 57 Entereg R 57 designed natriuretic peptide 57 ascending dose 57 null responder HCV 57 Nventa proprietary CoVal 57 journal Psychological Bulletin 57 ginkgo extract 57 h r i 57 evaluating REVLIMID 57 fosbretabulin 57 including eniluracil ADH 57 docetaxel Taxotere R 57 Clinicaltrials.gov 57 delta opioid receptor 57 Phase IIIb clinical 57 By CHIP MALAFRONTE 57 Mermin oversees 57 either acutely decompensated 57 #beta estradiol 57 acting angiotensin 57 granted Ortec 57 Adis Medunjanin awaits 57 CIMZIA ™ 57 Phase III Pivotal 57 induced macular edema 57 GRNOPC1 contains 57 Phase 2a clinical trials 57 NATRECOR ® 57 SPIRIT IV 57 R vitespen 57 angiotensin analog 57 Cholesterol Levels SPARCL 57 R#/MEM # 57 GOUT 57 Phase IIA 57 TELINTRA R 57 demonstrated clinically meaningful 57 generation rotary VAD 57 Ophena TM 57 sorafenib Nexavar R 57 Additionally Nexavar 57 GVAX ® 57 plus prednisone 57 PANVAC VF 57 Free apologetics 57 R NICOLET 57 CIMZIA TM 57 Erik Ostensoe P. Geo 57 HOPE TOO 57 masked placebo controlled 57 Eyvind Brynildsen Mitsubishi Lancer 57 DIRECT Trial 57 Populus interviewed random 57 announcing Kensinger censure 57 Patrick Garmoe Daily 57 PROACT Phase 2 57 Visit http:/www.Comtex.com 57 Folfox 57 Phase III VISTA 57 RG# ITMN 57 WAS BUT DEV 56 SmartChip TM product 56 BEXXAR Therapeutic Regimen 56 endothelin antagonists 56 Phase Ib 56 symptomatic pulmonary embolism 56 candidates Azedra TM 56 Trial Initiative LSTI 56 Commences Phase 56 Home Buyer Seller 56 Initiate Phase II 56 ENGAGE AF TIMI 56 By Neil Osterweil 56 ABSORB trial 56 Polygraph examinations 56 oral nucleoside analogue 56 Informatica Sets Date 56 PFO migraine 56 signal detection CTSD 56 home eldercare evaluation 56 randomized multicenter trial 56 APPRAISE 56 bronchial lavage 56 Hotel Indigo participates 56 Liveauctioneers.com bidders represent 56 oral prodrug 56 CRESTOR #mg 56 Randomized Evaluation 56 comparing alemtuzumab 56 Phase Ia 56 virologically suppressed 56 i h r 56 sNDA submission 56 OAB overactive bladder 56 SuperMedia specializes 56 telomerase inhibitor drug 56 Ovarian Cancer Screening 56 By Tona Kunz 56 biologic antibody 56 Nasdaq PGNX today 56 PSMA ADC 56 European Sepsis Trial 56 NIH registry www.clinicaltrials.gov 56 TBC# 56 CompX Reports 56 mg q#h 56 PRESCRIPTION DRUGS Gradually 56 Konashenkov allegations 56 Calmare pain 56 h r e 56 BLOOM DM 56 hugs Korin 56 Initiates Enrollment 56 PRE SURGE 56 Placebo Controlled 56 prospectively randomized 56 zoledronic acid Reclast 56 longitudinal cohort 56 Poti Lomaia 56 Elecsys Corporation Reports 56 agonistic human 56 EMPHASIS HF trial 56 MVA MUC1 IL2 56 JIM BARNES 56 TQT studies 56 GBM Minerals 56 ENDEAVOR III 56 Liraglutide Effect 56 Selzentry Celsentri 56 CENTRAL BAHAMAS 56 technology underlying Medidur 56 NMT Medical Announces 56 SPIRIT III 56 By BRENDAN KIRBY 56 SYNERGY Stent 56 YELLOWSTONE COUNTY 56 ONCONASE R 56 TransVax ™ 56 GRNVAC1 56 TRAIL receptor antibody mapatumumab 56 LungAlert TM 56 Oral Calcitonin 56 recurrent metastatic 56 REGEN trial 56 CUSTOM III 56 www.amvescap.com 56 hydrophobic docetaxel prodrug nanoparticle 56 transgenically produced product 56 CYP#A# CYP#D# 56 representing upland cotton 56 ZOLL resuscitation product 56 Tasigna prolongs 56 colleague Sana Inoue 56 Alzheimer Disease Cooperative 56 Matrox Bring 56 Axispoint specializes 56 HRPC ovarian cancer 56 SIX RO ROG 56 pharmacologically active isomer 56 Mg Uk 56 R rilonacept Injection 56 AIM HIGH 56 PharmaPros Corporation 56 placebo controlled 56 #mg QD [002] 56 multicentric 56 Traficet EN 56 Detection Evaluation 56 Gut Check aims 56 memantine HCl 56 weekly subcutaneous injections 56 AIR CF1 56 GCP compliant 56 Phase 2b study 56 Scandinavian Simvastatin Survival 56 MIRCERA 56 By Cailin Riley 56 Motesanib 56 EMBLEM TM 56 prospective longitudinal 56 DU #b 56 pralatrexate injection folate analogue 56 Multicenter Randomized Double 56 intravenous RSD# 56 commercial potash Sylvite 56 pharmacokinetic PK study 56 Fusion LTX 56 TO AVOID PREGNANCY WHILE 56 Privee indicated 56 Elotuzumab 56 Sports Writer spowell@gaffneyledger.com 56 NorStates Bank serves 56 secondary efficacy endpoints 56 florbetaben 56 Cannabinor 56 telaprevir dosed 56 Afatinib 56 doxorubicin cyclophosphamide 56 mg TID 56 By PEIJEAN TSAI 56 Quinamed 56 pharmacodynamic markers 56 tumor activated prodrug 56 Pharmacokinetic studies 56 Ocrelizumab 56 Allovectin 7 ® 56 Phase IIB 56 MoxDuo TM IR 56 oral FTY# 56 Ragweed Allergy 56 5 HT2A inverse 56 TOTTENHAM MANAGER HARRY REDKNAPP 56 lesinurad 56 Bipolar sufferers 56 randomized #:#:# 56 EDEMA3 trial 56 ZK EPO 56 eliglustat tartrate 56 unblinding 56 Santiago Chile Caracas Venezuela 56 VITAL Trial 56 tolevamer 56 dose pharmacokinetic 56 3hours #mins #.#secs M 56 pharmacokinetic parameters 56 xxxi adverse tax 56 RESTORE CLI trial 56 Daclizumab 56 evaluating nimotuzumab 56 migraine headaches AZ 56 www.sanbolic.com 56 Pagoclone